NEW YORK, July 22, 2015 /PRNewswire/ -- Morgan & Morgan
announces that it is investigating the Board of Directors of
Thoratec Corp. ("Thoratec" or the "Company") (THOR) for possible
breaches of fiduciary duty and other violations of law in
connection with the sale of the company to St. Jude Medical Inc.
(STJ).
If you own shares of Thoratec and would like to learn more about
the Thoratec shareholder investigation, you may contact Morgan
& Morgan at 1(800) 732-5200 or email
info@morgansecuritieslaw.com.
Under the terms of the proposed transaction, shareholders will
receive $63.50 in cash for each share
of Thoratec stock they own. The proposed transaction is valued at
approximately $3.4 billion. The
investigation relates to whether the proposal is fair to the public
shareholders of Thoratec and whether Thoratec's Board breached its
fiduciary duties in connection with the proposed sale.
About Morgan & Morgan
Morgan & Morgan is one of the nation's largest 200 law
firms. In addition to shareholder rights, the firm also
practices in the areas of antitrust, personal injury, consumer
protection, overtime, and product liability. All of the
Firm's legal endeavors are rooted in its core mission: provide
investor and consumer protection and always fight "for the
people."
Attorney advertising. Prior results do not guarantee a
similar outcome.
Contact:
Morgan & Morgan
Peter Safirstein, Esq.
28 West 44th Street
Suite 2001
New York, NY 10036
1-800-732-5200
info@morgansecuritieslaw.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/morgan--morgan-announces-the-investigation-of-thoratec-corp--thor-300117361.html
SOURCE Morgan & Morgan